Trials / Completed
CompletedNCT05575180
Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Waterloo · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A single-centered randomized doubled blinded placebo-controlled cross-over trial comparing two the effect of two carbonic anhydrase inhibitors on exercise performance in acute hypoxia. Participants will be young (under 40 years of age), healthy males and females who are regularly physically active.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetazolamide 250Mg Tab | Oral acetazolamide |
| DRUG | Methazolamide Pill | Oral Methazolamide |
| DRUG | Placebo | Oral placebo |
Timeline
- Start date
- 2023-08-11
- Primary completion
- 2024-02-22
- Completion
- 2024-02-22
- First posted
- 2022-10-12
- Last updated
- 2024-03-12
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05575180. Inclusion in this directory is not an endorsement.